ClinicalTrials.Veeva

Menu

The Role of Microbiota on the Development of Lung Cancer

X

Xiaorong Dong

Status

Unknown

Conditions

NSCLC Stage IV
NSCLC, Stage III
Healthy Subjects
NSCLC, Stage II
NSCLC, Stage I

Treatments

Other: without intervention type

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Relationship between human microbiota and epidemiology of lung cancer

Full description

In this study,We aim to find some kinds of human microbiota , which were associated with development of non-small cell lung cancer.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • non-small cell lung cancer patients

Exclusion criteria

  • long-term workers in the polluted environment, Patients who had used antibiotics within 1 month before sampling,

Trial design

100 participants in 2 patient groups

NCSLC group
Description:
NSCLC patients,including stage I to stage IV.
Treatment:
Other: without intervention type
Healthy subjects
Description:
healthy subjects
Treatment:
Other: without intervention type

Trial contacts and locations

1

Loading...

Central trial contact

dong xiaorong, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems